• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单纯疱疹病毒1型糖蛋白B的融合前结构、逃逸与中和作用

Prefusion structure, evasion and neutralization of HSV-1 glycoprotein B.

作者信息

Roark Ryan S, Schaub Andrew J, Shi Wei, Wang Maple, Bahna Fabiana A, Becker Jordan E, Biju Andrea, Chong Sue, Du Haijuan, Guo Yicheng, Hong Hsiang, Katsamba Phinikoula S, Mannepalli Seetha M, Olia Adam S, Ou Li, Rubin Sarah K, Sabo Yosef, Suleiman Mehin, Wells Malcolm L, Zhang Baoshan, Cheng Cheng, Glasgow Anum, Ho David D, Huang Yaoxing, Pierson Theodore C, Rawi Reda, Zhou Tongqing, Shapiro Lawrence, Kwong Peter D

机构信息

Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA.

Department of Biochemistry and Molecular Biophysics, Columbia University, New York, NY, USA.

出版信息

Nat Microbiol. 2025 Nov;10(11):2966-2980. doi: 10.1038/s41564-025-02153-x. Epub 2025 Oct 31.

DOI:10.1038/s41564-025-02153-x
PMID:41174178
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12578645/
Abstract

Glycoprotein B (gB) refolds between prefusion and postfusion conformations to facilitate herpesvirus entry into host cells. However, the isolation of prefusion-specific neutralizing antibodies, effective against other viral entry machines, has been challenging. Here we describe stabilization of the prefusion gB ectodomain from herpes simplex virus 1 (HSV-1), determine ectodomain structures at 2.9- to 4.1-Å resolution using cryogenic electron microscopy (cryo-EM) and isolate a prefusion-specific gB-neutralizing antibody termed WS.HSV-1.24. Murine immunization with gB stabilized in the prefusion conformation induced high titres of antibodies binding to both prefusion and postfusion gB, but-most notably-without measurable serum neutralization. Accessibility analysis revealed iso-surface exposure, with accessible surfaces on prefusion HSV-1 gB also exposed on postfusion gB. Structural analysis suggested substantial plasticity, with regions that refolded between pre- and postfusion conformations relegated to domain interfaces with limited accessibility; indeed, WS.HSV-1.24 recognized a domain-interface refolding region to facilitate neutralization. We propose that prefusion HSV-1 gB evades neutralization by most antibodies through an iso-surface display that is coupled to structural plasticity.

摘要

糖蛋白B(gB)在融合前和融合后构象之间重折叠,以促进疱疹病毒进入宿主细胞。然而,分离对其他病毒进入机制有效的融合前特异性中和抗体一直具有挑战性。在此,我们描述了单纯疱疹病毒1型(HSV-1)融合前gB胞外域的稳定化,使用低温电子显微镜(cryo-EM)在2.9至4.1埃分辨率下确定了胞外域结构,并分离出一种名为WS.HSV-1.24的融合前特异性gB中和抗体。用稳定在融合前构象的gB对小鼠进行免疫接种,诱导产生了高滴度的与融合前和融合后gB均结合的抗体,但最值得注意的是,没有可测量的血清中和作用。可及性分析揭示了等表面暴露,融合前HSV-1 gB上的可及表面在融合后gB上也有暴露。结构分析表明存在显著的可塑性,在融合前和融合后构象之间重折叠的区域位于可及性有限的结构域界面处;实际上,WS.HSV-1.24识别一个结构域界面重折叠区域以促进中和作用。我们提出,融合前HSV-1 gB通过与结构可塑性相关联的等表面展示来逃避大多数抗体的中和作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be06/12578645/adddc6a68b05/41564_2025_2153_Fig16_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be06/12578645/f6b4d3e8f7db/41564_2025_2153_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be06/12578645/d16f8acf00b2/41564_2025_2153_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be06/12578645/80159e83c8f8/41564_2025_2153_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be06/12578645/265be5d0f90d/41564_2025_2153_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be06/12578645/2d397f79293f/41564_2025_2153_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be06/12578645/a711bef2fa21/41564_2025_2153_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be06/12578645/5d2cf583973a/41564_2025_2153_Fig7_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be06/12578645/754f637af3b3/41564_2025_2153_Fig8_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be06/12578645/ce2908815488/41564_2025_2153_Fig9_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be06/12578645/ba778f506620/41564_2025_2153_Fig10_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be06/12578645/a5324ea6f528/41564_2025_2153_Fig11_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be06/12578645/5d00e3f16a7d/41564_2025_2153_Fig12_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be06/12578645/784049790bda/41564_2025_2153_Fig13_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be06/12578645/3965eee1151d/41564_2025_2153_Fig14_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be06/12578645/e90ec84b25cc/41564_2025_2153_Fig15_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be06/12578645/adddc6a68b05/41564_2025_2153_Fig16_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be06/12578645/f6b4d3e8f7db/41564_2025_2153_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be06/12578645/d16f8acf00b2/41564_2025_2153_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be06/12578645/80159e83c8f8/41564_2025_2153_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be06/12578645/265be5d0f90d/41564_2025_2153_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be06/12578645/2d397f79293f/41564_2025_2153_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be06/12578645/a711bef2fa21/41564_2025_2153_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be06/12578645/5d2cf583973a/41564_2025_2153_Fig7_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be06/12578645/754f637af3b3/41564_2025_2153_Fig8_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be06/12578645/ce2908815488/41564_2025_2153_Fig9_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be06/12578645/ba778f506620/41564_2025_2153_Fig10_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be06/12578645/a5324ea6f528/41564_2025_2153_Fig11_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be06/12578645/5d00e3f16a7d/41564_2025_2153_Fig12_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be06/12578645/784049790bda/41564_2025_2153_Fig13_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be06/12578645/3965eee1151d/41564_2025_2153_Fig14_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be06/12578645/e90ec84b25cc/41564_2025_2153_Fig15_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be06/12578645/adddc6a68b05/41564_2025_2153_Fig16_ESM.jpg

相似文献

1
Prefusion structure, evasion and neutralization of HSV-1 glycoprotein B.单纯疱疹病毒1型糖蛋白B的融合前结构、逃逸与中和作用
Nat Microbiol. 2025 Nov;10(11):2966-2980. doi: 10.1038/s41564-025-02153-x. Epub 2025 Oct 31.
2
A nanobody specific to prefusion glycoprotein B neutralizes HSV-1 and HSV-2.一种针对融合前糖蛋白B的纳米抗体可中和单纯疱疹病毒1型和单纯疱疹病毒2型。
Nature. 2025 Sep 3. doi: 10.1038/s41586-025-09438-5.
3
A human cytomegalovirus prefusion-like glycoprotein B subunit vaccine elicits humoral immunity similar to that of postfusion gB in mice.一种人巨细胞病毒预融合样糖蛋白B亚基疫苗在小鼠中引发的体液免疫与融合后gB相似。
J Virol. 2025 Jun 17;99(6):e0217824. doi: 10.1128/jvi.02178-24. Epub 2025 May 8.
4
The Fusion Loops of the Initial Prefusion Conformation of Herpes Simplex Virus 1 Fusion Protein Point Toward the Membrane.单纯疱疹病毒 1 融合蛋白初始融合构象的融合环指向细胞膜。
mBio. 2017 Aug 22;8(4):e01268-17. doi: 10.1128/mBio.01268-17.
5
Impact of valency of a glycoprotein B-specific monoclonal antibody on neutralization of herpes simplex virus.糖蛋白 B 特异性单克隆抗体的效价对单纯疱疹病毒中和作用的影响。
J Virol. 2011 Feb;85(4):1793-803. doi: 10.1128/JVI.01924-10. Epub 2010 Dec 1.
6
Glycoprotein C of Herpes Simplex Virus 1 Shields Glycoprotein B from Antibody Neutralization.单纯疱疹病毒 1 糖蛋白 C 可保护糖蛋白 B 免受抗体中和作用。
J Virol. 2020 Feb 14;94(5). doi: 10.1128/JVI.01852-19.
7
Conformational Changes in Herpes Simplex Virus Glycoprotein C.单纯疱疹病毒糖蛋白 C 的构象变化。
J Virol. 2022 Aug 24;96(16):e0016322. doi: 10.1128/jvi.00163-22. Epub 2022 Aug 1.
8
Targeting Herpes Simplex Virus Glycoprotein D with Bispecific Antibodies: Expanding Therapeutic Horizons by Searching for Synergy.用双特异性抗体靶向单纯疱疹病毒糖蛋白D:通过寻找协同作用拓展治疗视野
Viruses. 2025 Feb 12;17(2):249. doi: 10.3390/v17020249.
9
Cell Fusion Induced by a Fusion-Active Form of Human Cytomegalovirus Glycoprotein B (gB) Is Inhibited by Antibodies Directed at Antigenic Domain 5 in the Ectodomain of gB.细胞融合由人巨细胞病毒糖蛋白 B(gB)的融合活性形式诱导,该融合可被针对 gB 外结构域抗原表位 5 的抗体所抑制。
J Virol. 2020 Aug 31;94(18). doi: 10.1128/JVI.01276-20.
10
Extensive mutagenesis of the HSV-1 gB ectodomain reveals remarkable stability of its postfusion form.对 HSV-1 gB 胞外域进行广泛的诱变揭示了其融合后构象的惊人稳定性。
J Mol Biol. 2013 Jun 12;425(11):2056-2071. doi: 10.1016/j.jmb.2013.03.001. Epub 2013 Mar 13.

本文引用的文献

1
Site-resolved energetic information from HX-MS experiments.来自氢氘交换质谱(HX-MS)实验的位点解析能量信息。
Nat Chem Biol. 2025 Oct 17. doi: 10.1038/s41589-025-02049-1.
2
Structure-based design of a soluble human cytomegalovirus glycoprotein B antigen stabilized in a prefusion-like conformation.基于结构的可溶性人巨细胞病毒糖蛋白 B 抗原的设计,该抗原稳定在预融合样构象中。
Proc Natl Acad Sci U S A. 2024 Sep 10;121(37):e2404250121. doi: 10.1073/pnas.2404250121. Epub 2024 Sep 4.
3
Rapid simulation of glycoprotein structures by grafting and steric exclusion of glycan conformer libraries.
通过糖基 conformer 文库的嫁接和空间排斥作用快速模拟糖蛋白结构。
Cell. 2024 Feb 29;187(5):1296-1311.e26. doi: 10.1016/j.cell.2024.01.034.
4
ImmuneBuilder: Deep-Learning models for predicting the structures of immune proteins.免疫构建体:用于预测免疫蛋白结构的深度学习模型。
Commun Biol. 2023 May 29;6(1):575. doi: 10.1038/s42003-023-04927-7.
5
Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults.一种二价呼吸道合胞病毒预融合F疫苗在老年人中的疗效和安全性
N Engl J Med. 2023 Apr 20;388(16):1465-1477. doi: 10.1056/NEJMoa2213836. Epub 2023 Apr 5.
6
Targeting herpesvirus entry complex and fusogen glycoproteins with prophylactic and therapeutic agents.针对疱疹病毒进入复合物和融合糖蛋白的预防性和治疗性药物。
Trends Microbiol. 2023 Aug;31(8):788-804. doi: 10.1016/j.tim.2023.03.001. Epub 2023 Mar 24.
7
Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults.老年人呼吸道合胞病毒预融合F蛋白疫苗
N Engl J Med. 2023 Feb 16;388(7):595-608. doi: 10.1056/NEJMoa2209604.
8
Stabilized HIV-1 envelope immunization induces neutralizing antibodies to the CD4bs and protects macaques against mucosal infection.稳定的 HIV-1 包膜免疫诱导针对 CD4bs 的中和抗体,并保护猕猴免受粘膜感染。
Sci Transl Med. 2022 Sep 7;14(661):eabo5598. doi: 10.1126/scitranslmed.abo5598.
9
Vaccine-elicited murine antibody WS6 neutralizes diverse beta-coronaviruses by recognizing a helical stem supersite of vulnerability.疫苗诱导的小鼠抗体 WS6 通过识别一个脆弱性的螺旋茎超位点来中和多种β 冠状病毒。
Structure. 2022 Sep 1;30(9):1233-1244.e7. doi: 10.1016/j.str.2022.06.004. Epub 2022 Jul 15.
10
Structure of the rabies virus glycoprotein trimer bound to a prefusion-specific neutralizing antibody.与预融合特异性中和抗体结合的狂犬病病毒糖蛋白三聚体的结构
Sci Adv. 2022 Jun 17;8(24):eabp9151. doi: 10.1126/sciadv.abp9151.